Just In
- 2 hrs ago Heeramandi Screening: Alia Bhatt, Ananya Panday, Rashmika Mandanna And Others Serve Finest Ethnic Style!
- 2 hrs ago From Alia Bhatt To Kriti Sanon, Korean Beauty Products That Bollywood Divas Swear By
- 5 hrs ago Exclusive: On World Malaria Day 2024, Dr Shares Danger Signs Parents Must Watch Out For In Child With Malaria
- 6 hrs ago Exclusive: Expert Debunks 5 Common Misconceptions About Expectant Mothers That You Need To Steer Clear From
Don't Miss
- Finance Rs 7.50/Share Dividend: Adani Group Cement Company Reports Strong Q4 Results; Profit Surges 2x YoY
- Movies Heeramandi Premiere: Newly Engaged Aditi Rao Hydari Dazzles In A Multi-Coloured Anarkali Set; Guess The PRICE
- Education Tamil Nadu SSLC Results 2024: Number of Ways you can check the Results
- News Rajnath Singh Or Nitin Gadkari Could Have Been PM: Mamata Banerjee's Dig At BJP
- Automobiles Bajaj To Offer Chetak Electric Scooter At Lower Price Point: All Details Here
- Sports Bangladesh vs Zimbabawe: Will Shakib Al Hasan Play Home T20 Series In May Or Not?
- Technology Qualcomm Reveals Snapdragon X Plus Chip for Laptops: 10 Core CPU, On-Device AI, & Much More
- Travel Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
SII Seeks Permission For Phase-3 Study Of Covid Vaccine Covovax As Booster Dose In Adults
Serum Institute of India has sought permission from India's drug regulator to conduct a phase-3 study of its Covid-19 vaccine Covovax as a booster dose in adults, official sources said on Sunday.
The Drugs Controller General Of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December 28. The vaccine is yet to be included in the country's inoculation programme.
Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII had last week submitted an application to DCGI seeking nod for phase-3, observer-blind, randomised, controlled study to evaluate the safety and immunogenicity of Covovax as booster dose on those who have received primary vaccination either with Covishield or Covaxin at least three months ago, an official source said.
Singh has stated that many countries are already administering booster doses to their citizens considering the uncertainties of the COVID-19 pandemic.
"We are sure that your approval for conducting this clinical trial will ensure an early availability of Covovax for booster dose use for people of our country as well as the world in line with our prime minister's vision of 'Making in India for the World'," Singh is learnt to have stated in the application.
"Our firm is committed to providing world-class life-saving vaccines at an affordable price under the visionary leadership of our CEO Adar C Poonawalla. We request you to grant us permission to conduct a phase-3 clinical trial for booster dose of Covovax in Indian adults."
Covovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing authorisation and also granted emergency use listing by WHO.
In August 2020, the US-based vaccine maker Novavax Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India.
- pregnancy parentingMysterious Pneumonia Outbreak In China: What Are The Long-Term Effects Of Pneumonia In Children?
- healthCan You Get Back COVID-Related Loss Of Sense Of Smell And Taste (Parosmia)? Looks Like You Can!
- healthDid Covid-10 Vaccination Increase Risk Of Sudden Deaths In Young Adults? ICMR Finds This..
- wellnessDelhi Air Pollution, Air Quality Very Poor: Do Covid Masks Help Reduce Pollution Side Effects?
- healthNobel Prize 2023: Scientists Behind The COVID-19 mRNA Vaccines Wins
- healthWhat Is Disease X? 20 Times More Deadlier Than Covid 19; Can Cause 50 Million Deaths, Does It Have Vaccine?
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- healthDo You Pick Your Nose? Stop! It Can Increase COVID Risk
- healthEris Variant: WHO Alarms New Covid Wave; Should India Be Concerned About This Pandemic
- healthVitamin D Deficiency Linked With Increased Risk Of Long COVID
- healthCOVID Surge In India: Do You Need A COVID-19 Booster Shot?
- healthCOVID-19: IMA Cites 3 Reasons Behind Recent Surge In Covid-19 Cases: What Are They?